A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.
Identifieur interne : 001C00 ( Main/Exploration ); précédent : 001B99; suivant : 001C01A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.
Auteurs : H. Czajka [Pologne] ; S. Unal ; S. Ulusoy ; G. Usluer ; A. Strus ; E. Sennaroglu ; J. Guzik ; A. Topeli Iskit ; A. Dargiewicz ; D. Musial ; R. Caylan ; J. Dziduch ; E. Eskioglu ; B. Hasiec ; E. Cwinarowiczliwa ; R. Belli ; I A Abdel-Messih ; J. Beygo ; E. FragapaneSource :
- Journal of preventive medicine and hygiene [ 1121-2233 ] ; 2012.
Descripteurs français
- KwdFr :
- Adjuvants immunologiques (administration et posologie), Adulte, Adulte d'âge moyen, Anticorps antiviraux (sang), Anticorps neutralisants (sang), Facteurs de l'âge, Femelle, Grippe humaine (), Humains, Jeune adulte, Mâle, Polysorbates (administration et posologie), Sous-type H1N1 du virus de la grippe A (immunologie), Squalène (administration et posologie), Sujet âgé, Tests d'inhibition de l'hémagglutination, Tests de neutralisation, Vaccination (), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie).
- MESH :
- administration et posologie : Adjuvants immunologiques, Polysorbates, Squalène, Vaccins antigrippaux.
- immunologie : Sous-type H1N1 du virus de la grippe A, Vaccins antigrippaux.
- sang : Anticorps antiviraux, Anticorps neutralisants.
- Adulte, Adulte d'âge moyen, Facteurs de l'âge, Femelle, Grippe humaine, Humains, Jeune adulte, Mâle, Sujet âgé, Tests d'inhibition de l'hémagglutination, Tests de neutralisation, Vaccination.
English descriptors
- KwdEn :
- Adjuvants, Immunologic (administration & dosage), Adult, Age Factors, Aged, Antibodies, Neutralizing (blood), Antibodies, Viral (blood), Female, Hemagglutination Inhibition Tests, Humans, Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (prevention & control), Male, Middle Aged, Neutralization Tests, Polysorbates (administration & dosage), Squalene (administration & dosage), Vaccination (methods), Young Adult.
- MESH :
- chemical , administration & dosage : Adjuvants, Immunologic, Influenza Vaccines, Polysorbates, Squalene.
- chemical , blood : Antibodies, Neutralizing, Antibodies, Viral.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza Vaccines.
- methods : Vaccination.
- prevention & control : Influenza, Human.
- Adult, Age Factors, Aged, Female, Hemagglutination Inhibition Tests, Humans, Male, Middle Aged, Neutralization Tests, Young Adult.
Abstract
Effective planning and preparedness against a possible future A/H5N1 influenza pandemic is a major global challenge. Because dose sparing strategies are required to meet the global demand for vaccine, efforts have focused on the development of adjuvanted vaccine formulations of relatively lower antigen content.
PubMed: 23362618
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000A99
- to stream PubMed, to step Curation: 000A99
- to stream PubMed, to step Checkpoint: 000D55
- to stream Ncbi, to step Merge: 001575
- to stream Ncbi, to step Curation: 001575
- to stream Ncbi, to step Checkpoint: 001575
- to stream Main, to step Merge: 001C49
- to stream Main, to step Curation: 001C00
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.</title><author><name sortKey="Czajka, H" sort="Czajka, H" uniqKey="Czajka H" first="H" last="Czajka">H. Czajka</name><affiliation wicri:level="1"><nlm:affiliation>Provincial Children's Specialized Hospital, Krakow, Poland.</nlm:affiliation><country xml:lang="fr">Pologne</country><wicri:regionArea>Provincial Children's Specialized Hospital, Krakow</wicri:regionArea><wicri:noRegion>Krakow</wicri:noRegion></affiliation></author><author><name sortKey="Unal, S" sort="Unal, S" uniqKey="Unal S" first="S" last="Unal">S. Unal</name></author><author><name sortKey="Ulusoy, S" sort="Ulusoy, S" uniqKey="Ulusoy S" first="S" last="Ulusoy">S. Ulusoy</name></author><author><name sortKey="Usluer, G" sort="Usluer, G" uniqKey="Usluer G" first="G" last="Usluer">G. Usluer</name></author><author><name sortKey="Strus, A" sort="Strus, A" uniqKey="Strus A" first="A" last="Strus">A. Strus</name></author><author><name sortKey="Sennaroglu, E" sort="Sennaroglu, E" uniqKey="Sennaroglu E" first="E" last="Sennaroglu">E. Sennaroglu</name></author><author><name sortKey="Guzik, J" sort="Guzik, J" uniqKey="Guzik J" first="J" last="Guzik">J. Guzik</name></author><author><name sortKey="Topeli Iskit, A" sort="Topeli Iskit, A" uniqKey="Topeli Iskit A" first="A" last="Topeli Iskit">A. Topeli Iskit</name></author><author><name sortKey="Dargiewicz, A" sort="Dargiewicz, A" uniqKey="Dargiewicz A" first="A" last="Dargiewicz">A. Dargiewicz</name></author><author><name sortKey="Musial, D" sort="Musial, D" uniqKey="Musial D" first="D" last="Musial">D. Musial</name></author><author><name sortKey="Caylan, R" sort="Caylan, R" uniqKey="Caylan R" first="R" last="Caylan">R. Caylan</name></author><author><name sortKey="Dziduch, J" sort="Dziduch, J" uniqKey="Dziduch J" first="J" last="Dziduch">J. Dziduch</name></author><author><name sortKey="Eskioglu, E" sort="Eskioglu, E" uniqKey="Eskioglu E" first="E" last="Eskioglu">E. Eskioglu</name></author><author><name sortKey="Hasiec, B" sort="Hasiec, B" uniqKey="Hasiec B" first="B" last="Hasiec">B. Hasiec</name></author><author><name sortKey="Cwinarowiczliwa, E" sort="Cwinarowiczliwa, E" uniqKey="Cwinarowiczliwa E" first="E" last="Cwinarowiczliwa">E. Cwinarowiczliwa</name></author><author><name sortKey="Belli, R" sort="Belli, R" uniqKey="Belli R" first="R" last="Belli">R. Belli</name></author><author><name sortKey="Abdel Messih, I A" sort="Abdel Messih, I A" uniqKey="Abdel Messih I" first="I A" last="Abdel-Messih">I A Abdel-Messih</name></author><author><name sortKey="Beygo, J" sort="Beygo, J" uniqKey="Beygo J" first="J" last="Beygo">J. Beygo</name></author><author><name sortKey="Fragapane, E" sort="Fragapane, E" uniqKey="Fragapane E" first="E" last="Fragapane">E. Fragapane</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23362618</idno><idno type="pmid">23362618</idno><idno type="wicri:Area/PubMed/Corpus">000A99</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A99</idno><idno type="wicri:Area/PubMed/Curation">000A99</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A99</idno><idno type="wicri:Area/PubMed/Checkpoint">000D55</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D55</idno><idno type="wicri:Area/Ncbi/Merge">001575</idno><idno type="wicri:Area/Ncbi/Curation">001575</idno><idno type="wicri:Area/Ncbi/Checkpoint">001575</idno><idno type="wicri:doubleKey">1121-2233:2012:Czajka H:a:phase:ii</idno><idno type="wicri:Area/Main/Merge">001C49</idno><idno type="wicri:Area/Main/Curation">001C00</idno><idno type="wicri:Area/Main/Exploration">001C00</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.</title><author><name sortKey="Czajka, H" sort="Czajka, H" uniqKey="Czajka H" first="H" last="Czajka">H. Czajka</name><affiliation wicri:level="1"><nlm:affiliation>Provincial Children's Specialized Hospital, Krakow, Poland.</nlm:affiliation><country xml:lang="fr">Pologne</country><wicri:regionArea>Provincial Children's Specialized Hospital, Krakow</wicri:regionArea><wicri:noRegion>Krakow</wicri:noRegion></affiliation></author><author><name sortKey="Unal, S" sort="Unal, S" uniqKey="Unal S" first="S" last="Unal">S. Unal</name></author><author><name sortKey="Ulusoy, S" sort="Ulusoy, S" uniqKey="Ulusoy S" first="S" last="Ulusoy">S. Ulusoy</name></author><author><name sortKey="Usluer, G" sort="Usluer, G" uniqKey="Usluer G" first="G" last="Usluer">G. Usluer</name></author><author><name sortKey="Strus, A" sort="Strus, A" uniqKey="Strus A" first="A" last="Strus">A. Strus</name></author><author><name sortKey="Sennaroglu, E" sort="Sennaroglu, E" uniqKey="Sennaroglu E" first="E" last="Sennaroglu">E. Sennaroglu</name></author><author><name sortKey="Guzik, J" sort="Guzik, J" uniqKey="Guzik J" first="J" last="Guzik">J. Guzik</name></author><author><name sortKey="Topeli Iskit, A" sort="Topeli Iskit, A" uniqKey="Topeli Iskit A" first="A" last="Topeli Iskit">A. Topeli Iskit</name></author><author><name sortKey="Dargiewicz, A" sort="Dargiewicz, A" uniqKey="Dargiewicz A" first="A" last="Dargiewicz">A. Dargiewicz</name></author><author><name sortKey="Musial, D" sort="Musial, D" uniqKey="Musial D" first="D" last="Musial">D. Musial</name></author><author><name sortKey="Caylan, R" sort="Caylan, R" uniqKey="Caylan R" first="R" last="Caylan">R. Caylan</name></author><author><name sortKey="Dziduch, J" sort="Dziduch, J" uniqKey="Dziduch J" first="J" last="Dziduch">J. Dziduch</name></author><author><name sortKey="Eskioglu, E" sort="Eskioglu, E" uniqKey="Eskioglu E" first="E" last="Eskioglu">E. Eskioglu</name></author><author><name sortKey="Hasiec, B" sort="Hasiec, B" uniqKey="Hasiec B" first="B" last="Hasiec">B. Hasiec</name></author><author><name sortKey="Cwinarowiczliwa, E" sort="Cwinarowiczliwa, E" uniqKey="Cwinarowiczliwa E" first="E" last="Cwinarowiczliwa">E. Cwinarowiczliwa</name></author><author><name sortKey="Belli, R" sort="Belli, R" uniqKey="Belli R" first="R" last="Belli">R. Belli</name></author><author><name sortKey="Abdel Messih, I A" sort="Abdel Messih, I A" uniqKey="Abdel Messih I" first="I A" last="Abdel-Messih">I A Abdel-Messih</name></author><author><name sortKey="Beygo, J" sort="Beygo, J" uniqKey="Beygo J" first="J" last="Beygo">J. Beygo</name></author><author><name sortKey="Fragapane, E" sort="Fragapane, E" uniqKey="Fragapane E" first="E" last="Fragapane">E. Fragapane</name></author></analytic><series><title level="j">Journal of preventive medicine and hygiene</title><idno type="ISSN">1121-2233</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjuvants, Immunologic (administration & dosage)</term><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Antibodies, Neutralizing (blood)</term><term>Antibodies, Viral (blood)</term><term>Female</term><term>Hemagglutination Inhibition Tests</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Male</term><term>Middle Aged</term><term>Neutralization Tests</term><term>Polysorbates (administration & dosage)</term><term>Squalene (administration & dosage)</term><term>Vaccination (methods)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adjuvants immunologiques (administration et posologie)</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps antiviraux (sang)</term><term>Anticorps neutralisants (sang)</term><term>Facteurs de l'âge</term><term>Femelle</term><term>Grippe humaine ()</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Polysorbates (administration et posologie)</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Squalène (administration et posologie)</term><term>Sujet âgé</term><term>Tests d'inhibition de l'hémagglutination</term><term>Tests de neutralisation</term><term>Vaccination ()</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adjuvants, Immunologic</term><term>Influenza Vaccines</term><term>Polysorbates</term><term>Squalene</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Neutralizing</term><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Adjuvants immunologiques</term><term>Polysorbates</term><term>Squalène</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term><term>Anticorps neutralisants</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Female</term><term>Hemagglutination Inhibition Tests</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neutralization Tests</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de l'âge</term><term>Femelle</term><term>Grippe humaine</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Sujet âgé</term><term>Tests d'inhibition de l'hémagglutination</term><term>Tests de neutralisation</term><term>Vaccination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Effective planning and preparedness against a possible future A/H5N1 influenza pandemic is a major global challenge. Because dose sparing strategies are required to meet the global demand for vaccine, efforts have focused on the development of adjuvanted vaccine formulations of relatively lower antigen content.</div></front></TEI><affiliations><list><country><li>Pologne</li></country></list><tree><noCountry><name sortKey="Abdel Messih, I A" sort="Abdel Messih, I A" uniqKey="Abdel Messih I" first="I A" last="Abdel-Messih">I A Abdel-Messih</name><name sortKey="Belli, R" sort="Belli, R" uniqKey="Belli R" first="R" last="Belli">R. Belli</name><name sortKey="Beygo, J" sort="Beygo, J" uniqKey="Beygo J" first="J" last="Beygo">J. Beygo</name><name sortKey="Caylan, R" sort="Caylan, R" uniqKey="Caylan R" first="R" last="Caylan">R. Caylan</name><name sortKey="Cwinarowiczliwa, E" sort="Cwinarowiczliwa, E" uniqKey="Cwinarowiczliwa E" first="E" last="Cwinarowiczliwa">E. Cwinarowiczliwa</name><name sortKey="Dargiewicz, A" sort="Dargiewicz, A" uniqKey="Dargiewicz A" first="A" last="Dargiewicz">A. Dargiewicz</name><name sortKey="Dziduch, J" sort="Dziduch, J" uniqKey="Dziduch J" first="J" last="Dziduch">J. Dziduch</name><name sortKey="Eskioglu, E" sort="Eskioglu, E" uniqKey="Eskioglu E" first="E" last="Eskioglu">E. Eskioglu</name><name sortKey="Fragapane, E" sort="Fragapane, E" uniqKey="Fragapane E" first="E" last="Fragapane">E. Fragapane</name><name sortKey="Guzik, J" sort="Guzik, J" uniqKey="Guzik J" first="J" last="Guzik">J. Guzik</name><name sortKey="Hasiec, B" sort="Hasiec, B" uniqKey="Hasiec B" first="B" last="Hasiec">B. Hasiec</name><name sortKey="Musial, D" sort="Musial, D" uniqKey="Musial D" first="D" last="Musial">D. Musial</name><name sortKey="Sennaroglu, E" sort="Sennaroglu, E" uniqKey="Sennaroglu E" first="E" last="Sennaroglu">E. Sennaroglu</name><name sortKey="Strus, A" sort="Strus, A" uniqKey="Strus A" first="A" last="Strus">A. Strus</name><name sortKey="Topeli Iskit, A" sort="Topeli Iskit, A" uniqKey="Topeli Iskit A" first="A" last="Topeli Iskit">A. Topeli Iskit</name><name sortKey="Ulusoy, S" sort="Ulusoy, S" uniqKey="Ulusoy S" first="S" last="Ulusoy">S. Ulusoy</name><name sortKey="Unal, S" sort="Unal, S" uniqKey="Unal S" first="S" last="Unal">S. Unal</name><name sortKey="Usluer, G" sort="Usluer, G" uniqKey="Usluer G" first="G" last="Usluer">G. Usluer</name></noCountry><country name="Pologne"><noRegion><name sortKey="Czajka, H" sort="Czajka, H" uniqKey="Czajka H" first="H" last="Czajka">H. Czajka</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C00 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C00 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23362618
|texte= A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23362618" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |